Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{185710,
        author = {Mr. Mujeeb Muhamadhusen Shaikh and Sadaf rafik ansari and Nishat ashfaque rawoot and Zainab Muzammil shingre and RUHAB DILDAR DHANSAY and Zakiya tahir shaikh},
        title = {Democracy and Pharmaceutical Regulation: Ensuring Justice in Healthcare},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {5},
        pages = {3711-3713},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=185710},
        abstract = {In democratic societies, healthcare is considered a fundamental right, and equitable access to medicines is an essential component of public welfare. Pharmaceutical regulation is critical to ensuring that drugs are safe, effective, and accessible. Democracy plays a crucial role in shaping these regulations by embedding principles of transparency, accountability, and public participation into healthcare policies. A democratic framework ensures that regulatory decisions are not solely influenced by industry or political pressure but reflect the collective interest of society, thereby promoting justice in healthcare. This paper reviews the role of democratic governance in pharmaceutical regulation, highlights challenges, and proposes strategies to enhance equity and ethical practice in healthcare delivery.},
        keywords = {— Democracy, Pharmaceutical Regulation, Healthcare Justice, Public Health Policy, Transparency, Accountability, Access to Medicines, Legal Frameworks, Public Participation, Equity},
        month = {October},
        }